Persistent immunological changes 55 months after PBPCT. Is the restoration of immune function possible with a longer follow-up?
We read with interest the article by Nordøy et al 1 dealing with the persistent changes in immune function 4-10 years after ABMT. The authors show that the early changes in the immune system observed after ABMT, in particular a reduction of CD4 and normalization of CD8 resulting in a decreased CD4/CD8 ratio, persist after a median of 5 years. On the basis of our experience we can confirm these findings also in the setting of autologous peripheral stem cell transplantation. Since 1996 we have studied 40 patients (25 male; 15 female) with a median age of 36 years (range 19-60 years) undergoing peripheral blood selected (CD34 + ) (nine patients) or unselected autologous stem cell transplantation (31 patients). Reasons for transplantation were: nonHodgkin's lymphoma (26 patients), Hodgkin's lymphoma (14 patients) (patient characteristics are shown in Table 1 ). The purpose of the study was to investigate immunological reconstitution using a test panel (CD3, CD19, CD4, CD8, CD4/CD8, CD16/56, CD3HLADR). All patients entering the study were required to have had at least 12 months follow-up, and to be in continuous complete remission after PBPCT without any chemo-radiotherapy or biological response modifier. We performed annual follow-ups, studying 73 controls with a median of two controls per patient (range 1-3). We arbitrarily subdivided patients into three groups according to the time and number of controls per patient: group A, 35 patients with a median follow-up of 14 months (range 12-65 months); group B, 22 patients with a median follow-up of 28 months (range 24-82 months); and group C, 15 patients with a median follow-up of 55 months (range 36-96 months). We observed a persistent reduction in CD4 T lymphocytes with a trend for normalization without statistical differences between the three groups. CD8 assay showed values around the normal range in groups A and B with normalization in the third group. Recovery of CD4 and normalization of CD8 produced a trend for recovery of the CD4/CD8 ratio with statistical differences between groups A and C (Kruskal-Wallis posthoc test P = 0.007). Total T lymphocytes were constantly in the normal range and total B lymphocytes were high with respect to normal values, in all groups. Effector cells including activated T lymphocytes (CD3-HLA-DR) and natural killer (CD16-56) were persistently above the normal range without statistical differences in the three groups (results are shown in Table 2 ).
As did Nordøy et al 1 we confirmed a tendency towards higher CD4 counts between the three groups even if statistical significance was not reached. Concomitantly, CD8 cells progressively decreased to the normal range in group C. These data, confirmed by previous studies, [2] [3] [4] show a trend to normalization of the CD4/CD8 ratio that is statistically significant with prolonged follow-up. In conclusion, we demonstrated that the normalization process of CD4 and CD8 cells continues even after many years so that restoration of immune function may be possible with extended follow-up after PBSCT.
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The fact that many patients who have undergone high-dose therapy with autologous stem cell support are long-term survivors makes studies on possible late effects important. Hence, we appreciate Laurenti and co-workers' comments on long-term immunological reconstitution after PBSCT. In this issue of Bone Marrow Transplant they present interesting data showing that subsets of lymphocytes are still altered several years after treatment. Like Laurenti, we observed that levels of CD4 + T cells and CD4/CD8 ratios were below normal levels in a group of lymphoma patients 4-10 years post ABMT. 1 Both studies report normal numbers of CD8
+ cells and a moderate increase in B cells. In our study, a higher percentage of stimulated CD4
+ T cells produced IL-4 compared to controls, indicating a dominant Th2 response. This might help explain why numbers of B cells are increased. Unlike Laurenti and colleagues, we could not detect levels of NK cells above normal. These two reports are of particular importance because they are the first to investigate alterations in the immune system more than 5 years after high-dose therapy. It is interesting to observe that the situation after ABMT and PBSCT seems to be very similar.
By comparing three groups of patients at different time points after PBSCT, Laurenti was able to observe a trend towards recovery of CD4 + T cells and normalization of CD4/CD8 ratios. A similar observation was made in our previous study comparing patients transplanted 4-6 years and 7-10 years ago. Data are shown in Table 1 . There was not, however, complete restoration, even in the group with the longest follow-up. When looking at subsets of CD4 + T cells, the ABMT patients had a significantly higher fraction of the CD45RO (memory) subset compared to controls, whereas the CD45RA (naive) subset was reduced (Table 1) . No tendency towards normalization of this imbalance could Table 1 Data are given as median and ranges be found when comparing patients transplanted 4-6 and 7-10 years ago. This supports the notion that maturation of T cells in the thymus is permanently impaired in adults and questions whether normal numbers of naive and memory T cells can ever be restored. Numbers in T cell subsets are altered many years after PBSCT and ABMT, but perhaps more important might be their function. We made an attempt to investigate this by looking at the production of cytokines after mitogen stimulation in CD4 + CD45RA + and CD4 + CD45RO + cells ( Table 1 ). The percentage of cells producing ␥-IFN or IL-4 was increased compared to controls and no tendency toward normalization could be observed. In addition, the patients have completed a vaccination program and these results will add information regarding immune function. We conclude, that even though the data indicate that recovery of CD4 + cells and CD8 + cells might take place over time, this does not necessarily mean that levels of naive (CD45RA) and memory (CD45RO) T cells normalize. Furthermore, there might be more permanent alterations in T cell function. A longer follow-up of patients after ABMT and PBSCT is important to find out whether the immune system is indeed completely restored.
